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This paper will examine the impacts of obesity in 
aviation medicine. The World Health Organisation 
(WHO) has described the problems of obesity and 
being overweight as one of the greatest public 
health challenges of the 21st century (1) and this 
will certainly lead to increasing numbers of obese 
aviators (or potential aviators) presenting for 
medical certification. These people may not 
realise the impact their increased weight could 
have on their flying career and is often going to be 
an incidental finding in their examination rather 
than the specific problem they present with. This 
leads to the question for the medical examiner, 
does being overweight/obese matter in aviation 
and how might it increase a person’s risk of 
incapacitation in the cockpit? 
 
OBESITY 
The WHO defines overweight and obesity as 
abnormal or excessive fat accumulation that may 
impair health (1). Body mass index (BMI) is a 
person’s weight in kilograms divided by the square of 
height in meters, which can be used to screen for 
weight categories. The WHO defines obesity as a 
BMI of greater than or equal to 30 and being 
overweight is defined as a BMI of greater than or 
equal to 25 (1). Recent WHO estimates suggest that 
in 2016 39% of adults were defined as overweight 
and 13% were obese and this is rising, with 
prevalence tripling in some countries since the 
1980’s. 
The exact prevalence of obesity amongst all pilots is 
not clear and there is likely to be significant variation 
between differing types of aviators. Military members 
flying physically demanding jets are much less likely 
to be obese by virtue of the job they do and their 
organisational fitness requirements and 
anthropometric requirements. Private or long haul 
commercial pilots may lead a more sedentary 
working life. A recent Brazilian study (2) found a 
prevalence of 53.7% of pilots being defined as 
overweight and 14.6% being obese. This is similar to 
other study results (3,4).  
Being overweight or obese is a major risk factor for 
developing many other conditions including 
cardiovascular disease, venous thromboembolic 
disease (VTE), hypertension, type 2 diabetes, 
obstructive sleep apnoea (OSA), musculoskeletal 
conditions (including osteoarthritis), mental health 
issues and some cancers. The risk increases with 
increased BMI (1,5). Clearly all of these disease 
processes, their complications, as well as the actual 
physical size of the person have significant 
ramifications for current or potential aircrew medical 
certification and will be discussed further below. 
 
TREATMENTS AVAILABLE FOR OBESITY 
Obesity is a complex chronic multifactorial disease. 
Genetic, nutritional, medical, pharmacological, socio-
economic and lifestyle factors all play a part and 
therefore it makes sense that multifaceted 
interventions will be more effective than a single 
treatment. The National Health and Medical 
Research Council have developed Obesity 
Guidelines (6) to assist primary health care providers 
in initially managing this complex condition, ensuring 
that an accurate assessment is done, with referral for 
appropriate therapies if required. These guidelines 
provide a stepwise framework called the 5A’s 
approach. Some patients will need very little input 
escalating up to those who require multiple 
management strategies. 
 
Ask and Assess, Advise, Assist and Arrange 
This encompasses asking patients, who are, in our 
case aviators, specifically about their weight and if 
they perceive it to be a problem and if they have the 
desire and motivation to lose weight? A thorough 
history can help to establish if being overweight has 
been a chronic life long pattern which will likely need 
much more intensive and long term strategies to 
manage, or, if it is an acute new issue. Recent new 
weight gain can be associated with a number of 
factors such as recent smoking cessation, some 
 
pharmacological agents (for example the oral 
contraceptive pill) or acute life stressors (marital or 
employment issues) and in this case strategies 
should be directed at dealing with the underlying 
issues as well as weight loss. 
An accurate BMI and also waist circumference 
should be undertaken to stratify the extent of the 
problem and guide referral and treatment choices.  
Waist circumference predicts total body fat and may 
help refine the risk of cardiovascular disease and 
diabetes (6). The greater the circumference the 
greater the risk.  
Advising patients that there is clear evidence that 
even losing a small amount of weight can bring 
significant health improvements (7) can provide 
motivation for weight loss, particularly to aviators who 
may not realise the impact their weight might have on 
their flying career. It is then the role of the primary 
health care provider to assist and arrange (if 
required) referral on to specialist providers for further 
evaluation and treatment. This may involve drug 
treatments, surgery, multi disciplinary allied health 
input or a combination of those strategies. 
 
Pharmacotherapy for Obesity 
It is suggested that drug therapy may be considered 
for patients with a BMI > 30 (5,8,9). The Therapeutic 
Goods Administration (TGA) currently approves 
Phentermine, Orlistat and Liraglutide in Australia for 
the treatment of obesity. Topiramate is also used 
although its use in the treatment of obesity is off 
label. Unfortunately all these drugs come with the 
potential of significant side effects making them 
unsuitable for use in pilots currently flying due to the 
risks of incapacitation. These are discussed further 
below. 
Phentermine is a sympathomimetic agent, which 
suppresses appetite. It has the potential to cause 
arrhythmias, gastrointestinal (GI) upset, insomnia 
and hypertension (10) This could lead to sudden 
acute incapacitation from loss of consciousness and 
cardiovascular collapse due to a malignant 
arrhythmia. Palpitations or an acute gastrointestinal 
upset may lead to distraction and insomnia can lead 
to fatigue and subtle decreases in cognition and 
ability. It is prohibited for use whilst flying by the Civil 
Aviation Safety Authority  (CASA) of Australia (15) 
Orlistat is a GI lipase inhibitor essentially preventing 
fat absorption in the gut. Up to 27% of people taking 
this will suffer from significant GI side effects 
including an oily rectal leakage, flatulence with 
discharge and abdominal pain (10), clearly making 
the risk of incapacitation very significant and thus 
unsuitable for use. It also associated with headaches 
and other side effects. 
Liraglutide is a glucagon like peptide used to treat 
type 2 diabetes (10,11). It was found to cause a 
decreased appetite in some patients so subsequently 
has been used in the treatment of weight loss. 
Unfortunately it comes with the risk of significant GI 
side effects, the potential to cause hypoglycaemia 
(particularly in those taking a sulphonylurea) and 
electrocardiographic (ECG) changes (11)  rendering 
it unsuitable for use in aviators. 
Topiramate is an anticonvulsant that has been used 
to treat obesity off label (10,11). As with most anti 
epileptic drugs, topiramate comes with a myriad of 
side effects that could cause potential incapacitation 
in the cockpit. Psychiatric issues causing overt 
delusions or suicidal behaviours, acute angle 
glaucoma leading to intense eye pain or blindness 
are amongst the problems.  
 
Bariatric Surgery for Obesity 
A 2014 Cochrane review (12) found that surgery for 
obesity resulted in greater weight loss than other 
treatments in the short term and also reduced some 
co morbidities. It suggests that bariatric surgery may 
be considered for people with a BMI of >40 or less 
than 40 with obesity related diseases (eg diabetes) 
where other methods have failed. Unfortunately, 
most of the studies involved only measured 
outcomes up to 2 years so the true long-term 
outcomes are not known. The most common 
procedures in Australia are the adjustable gastric 
band, the sleeve gastrectomy and the roux-en-Y 
bypass (13) all of which have similar complications 
which may impact on the ability to fly safely 
afterwards. These include acute surgical 
complications such as bowel perforation or 
anastomotic leaks and post operative infections. 
These issues should be addressed and treated 
during the postoperative recovery period and if 
successfully managed pose no long term risk to 
medical certification in the future. Obviously if a pilot 
was to embark on weight loss surgery they would 
require a period of grounding until they demonstrated 
a full recovery. 
Unfortunately longer-term complications may arise 
from all of these procedures that could cause 
potential issues for medical certification. Dumping 
syndrome can occur in up to 50% of people post 
gastric bypass when high levels of simple 
 
carbohydrates are ingested leading to a rapid fluid 
shift from the plasma to the bowel and causing 
hypotension, tachycardia with possible diarrhoea and 
nausea. Hyperinsulinaemic hypoglycaemia is another 
complication that could cause acute incapacitation. 
Other conditions associated long term post bariatric 
surgery are iron deficiency anaemia, vitamin B12 
deficiency and thiamine deficiency. 
In the case of gastric band surgery over restriction of 
the band may be a problem causing discomfort and 
the inability to keep food down  (13). 
 
Multidisciplinary Allied Health Input 
It has been shown that behavioural based programs 
improve weight loss results (14) and referral may be 
needed to dietitians, psychologists or exercise 
physiologists to aid initial weight loss and maintain 
the loss. 
 
EFFECTS OF THE AVIATION ENVIRONMENT ON PEOPLE 
WHOM ARE OBESE OR WHO ARE BEING TREATED FOR 
OBESITY AND ITS RELATED COMPLICATIONS 
The aviation environment can be considered as 
hostile. Pilots operate in a cockpit which is restrictive 
in space, there are barometric pressure differences, 
relative hypoxia, and vibration all of which can impact 
on the obese pilot more so than the none obese pilot. 
These will obviously vary between airframes. The 
single seat unpressurised helicopter will be very 
different to a large pressurised climate controlled 
A380.  
The small cockpit space may limit movement during 
flight leading to a further increased risk of 
thromboembolic events (15,16). This, along with 
vibration may exacerbate chronic pain issues such as 
lower back pain and worsen conditions such as 
venous ulcers causing distracting pain. 
Those with a gastric band run the risk of over 
restriction leading to discomfort and the inability to 
eat and drink normally, this is due to expansion of the 
band (or small air bubbles with in the band) at 
altitude due to decreased barometric pressure. 
Several gastric band information sites suggest 
removal of some of the liquid prior to a long haul 
flight to prevent this (17) but it is unclear what this 
would mean for a pilot flying often. 
Hypoxia at altitude may be of concern due to obesity 
hypoventilation syndrome giving rise to subtle 
cognitive defects especially in small unpressurised 
airframes. 
If the pilot is working in the long haul sector with 
stopovers and transiting multiple time zones then 
timing of medications and availability of regular food 
required for associated conditions (such as type 2 
diabetes or post gastric surgery) may become a 
problem, as would be the logistics of managing a 
continued positive airway pressure (CPAP) machine 
if required for OSA. 
 
EFFECTS OF PERSON’S PHYSICAL SIZE AND WEIGHT 
The obese pilot may be unable to egress the aircraft 
safely in an emergency, be unable to fit through 
emergency exits or manoeuvre themselves quickly 
out of the cockpit. They may also have difficulty 
utilising life saving equipment such as life jackets. 
Seats may be too small to fit into comfortably and the 
safety harnesses may not fit, all of which are 
incompatible for safe operations. 
They may also be physically unable to do external 
pre-flight checks if these are required, and potentially 
have difficulty operating the controls. 
If the pilot is very big and the plane is very small 
there could be a dramatic effect on the weight and 
balance of the plane leading to safety issues. CASA 
recommends a morbidly obese pilot provide a 
completed calculated weight and balance sheet to be 
provided during the certification process (15) if a 
small plane is to be flown to prevent safety issues 
occurring. 
 
Risk of Incapacitation Due to Obesity Related 
Conditions or Their Treatments 
The range of medical conditions associated with 
being obese is nearly endless which makes 
evaluation very complex. This is also true for the 
extensive treatments that could be involved. Below is 
a review of some of the more common conditions 
occurring, but these are by no means exhaustive. 
Many of these conditions alone require grounding 
periods for pilots and potential restrictions on 
certification. 
Cardiovascular disease may cause overt sudden 
incapacitation due to an acute myocardial infarction 
or cerebrovascular event. Distraction from pain or 
dyspnoea caused by angina or cardiac failure. 
Confusion or transient neurological issues due to 
transient ischaemic attacks is a risk. 
Respiratory issues include OSA and is a particular 
strongly associated with obesity (5). It can cause 
 
sudden incapacitation due to hypersomnolence and 
also some more   subtle decreases in cognition and 
difficulty concentrating which may go unnoticed. It 
also independently increases the risk for many other 
conditions. Obesity hypoventilation syndrome may 
lead to hypoxia and impaired cognition at altitude. 
Pulmonary embolus can lead to sudden 
incapacitation and treatment of VTE disease with 
anticoagulants have their own risks of bleeding and 
incapacitation. 
Being overweight or obese has been shown to be 
associated with depressive illness (and vice versa) 
(18). This, along with the stigma that may be felt by 
the person due to excess weight, leads to a potential 
risk of overt suicidality or self-harming behaviour that 
makes certification difficult. Depression alone can 
cause fatigue and cognitive dysfunction that may 
lead to errors in the cockpit. 
 Type 2 diabetics are at risk of hypo or 
hyperglycaemic episodes (depending on treatments) 
leading to incapacitation and also long-term 
complications such as visual and neurological 
problems, which may lead to subtle decrease in 
performance. 
Other complications include but are not limited to are: 
gall bladder disease, osteoarthritis, lower back pain, 
venous ulcers and stress incontinence, these may 
not cause immediate catastrophic issues however 
have the potential to distract the pilot leading to 
errors and decreased performance. 
Many people will have several issues to address. 
 
Risk of Incapacitation Due to Obesity Treatments 
Surgical treatment has been discussed above, as 
has the disqualifying nature of appetite suppressants. 
Toxicological analysis post mortem found that the 
drugs found in obese pilots involved in a fatal 
accident were similar to that for the general pilot 
population (19) which would indicate that obese pilots 
are not generally flying whilst using weight loss 
treatments covertly, which is reassuring. 
 
GUIDANCE AVAILABLE FROM AUTHORITIES 
The International Civil Aviation Authority (ICAO), 
Federal Aviation Administration (FAA) and the Civil 
Aviation Authority of New Zealand (CAA NZ) do not 
provide any specific guidelines on the approach to 
certifying an obese pilot, only advice on how to 
manage associated conditions. However it has been 
shown that obese aviators in the US are more likely 
to require a special issuance medical clearance than 
their non-obese counterparts (5) presumably due to 
increased prevalence of complex problems. 
The Civil Aviation Authority of the United Kingdom 
have guidance when a person presents with a BMI > 
35 (20) but nothing for those with <35. 
CASA, however, has comprehensive guidelines 
regarding the approach to medical certification (15). 
They suggest assessment be broken down into 
operational constraints, complications of obesity, 
treatment issues and then demonstrated stability (of 
treatment and of weight). They have a risk 
assessment protocol based on BMI and age which 
would guide further information and testing required. 
This includes but is not limited to:  
• Fasting glucose tolerance test 
• Sleep Study 
• CASA cardiovascular risk profile and if required 
evaluation by a cardiologist/physician 
• Operational check conducted by an approved 
officer (CASA Flight Operations Inspector/CASA 
Safety Approved Test Officer/local Chief Flying 
Instructor) 
There is no mention specifically of air traffic 
controllers in the CASA guideline. 
 
SUMMARY 
Obesity is a complex and multifactorial issue with 
multiple interconnections and feed back loops 
between the original condition, treatments and 
complications.  Developing one complication can 
often lead to the risk of developing another. For 
example, developing type 2 diabetes increases your 
risk of cardiovascular disease. Developing OSA (in 
addition to leading to hypertension and thus 
cardiovascular disease) can make you fatigued, more 
sedentary and thus more obese. Treatments for 
conditions associated with obesity may be 
incompatible with medical certification or at the very 
least mean the person needs to fly with a multicrew 
restriction. 
In general, the more obese the individual the more 
comprehensive the evaluation will need to be. Mildly 
overweight pilots may respond well to counselling 
regarding diet and lifestyle and be very motivated 
especially if they realise that further weight gain could 
jeopardize their flying career. Uncomplicated bariatric 
surgery and a period of grounding with no 
 
complications also has a favourable outcome for 
certification. 
The use of appetite suppressants and uncontrolled 
complications of obesity have an unfavourable 
outcome with regards to certification (15) 
As with most things in aviation medicine there is no 
clear answer in regards to the obese individuals 
fitness to fly. They will have to be assessed on a 
case-by-case basis and take into account the type of 
certification they require, the aircraft they are 




1.  Obesity and overweight [Internet]. Who.int. 2020 
[accessed 16 August 2020]. Available from: 
https://www.who.int/news-room/fact-
sheets/detail/obesity-and-overweight 
2.  de Souza Palmeira M, Cristina Marqueze E. 
Excess weight in regular aviation pilots associated 
with work and sleep characteristics. Sleep Sci. 
2016 Oct;(4):266-271.  
3.  Qiang Y, Li G, Rebok G, Baker S. Body Mass 
Index and Cardiovascular Disease in a Birth 
Cohort of Commuter Air Carrier and Air Taxi 
Pilots. Ann Epidemiol. 2005 Apr;15(4):247-252.  
4. Bhat K, Verma N, Pant P, Singh Marwaha M. 
Hypertension and Obesity Among Civil Aviation 
Pilots. Aerosp Med Hum Perform. 2019 
Aug;90(8):703-708.  
5.  Bryman D, Mills W. Co-morbid conditions in 
overweight and obese airmen. Aviat Space and 
Environ Med. 2007 Jul;78(7):702-705.  
6.  Overweight and obesity: an interactive insight, 
Causes - Australian Institute of Health and 
Welfare [Internet]. Australian Institute of Health 





7.  Summary guide for the management of 
overweight and obesity in adults, adolescents and 
children in Australia [Internet]. National Health and 
Medical Research Council. 2013 [accessed 16 




8.  Jensen M, Ryan D, Apovian C, Ard J, Comuzzie 
A, Donato K et al. 2013;AHA/ACC/TOS Guideline 
for the Management of Overweight and Obesity in 
Adults. Circ, 2014 Jun; 129(25 suppl 1), pp.S102-
S138. 
9.  Apovian C, Aronne L, Bessesen D, McDonnell M, 
Murad, M, Pagotto U et al. Pharmacological 
Management of Obesity: An Endocrine Society 
Clinical Practice Guideline. J Clin Endicrinol 
Metab. 2015 Feb;100(2), pp.342-362. 
10. MIMMS Online [internet] Australia. July 2020. 
Available from http://www.mimsonline.com.au 
[accessed 20 Jul 2020] 
11. Lee P, Dixon, J. Pharmacotherapy for obesity. 
AFP, 2017 Jul; 46(7), pp.472-477. 
12. Colquitt J, Pickett K, Loveman E et al. Surgery for 
weight loss in adults. Cochranelibrary.com. 2020. 
[online] Available at: 
<https://www.cochranelibrary.com/cdsr/doi/10.100
2/14651858.CD003641.pub4/pdf/CDSR/CD00364
1/CD003641_abstract.pdf> [Accessed 16 August 
2020]. 
13. Lee P, Dixon J. Bariatric-metabolic surgery: A 
guide for the primary care physician.  AFP, 2017 
Jul;46(7), pp.465-471. 
14. Perreault L. Obesity in adults: Behavioural 
therapy. In: Pi-Sunyer F X, Kunins L, editors; Up 
to Date [internet]. Waltham (MA) Up to Date Inc; 








15. Australian Government Civil Aviation Safety 
Authority, DAME Clinical Practice Guidelines – 
Obesity [internet] Australia. August 2020. 
Available from https://www.casa.gov.au//licences-
and-certification/aviation-medicine/obesity  
[accessed 16 Jul 2020] 
16. Gavish I, Brenner B. Airtravel and the risk of 
thromboembolism. Intern Emerg Med .2011 
Apr;6:113-6. doi 10.1007/s11739-010-0474-6 
17. The Sydney Institute of Obesity Surgery. The 




guide-pdf [accessed 19 Aug 2020] 
 18.Luppino FS, de Wit LM, Bouvy PF, et al. 
Overweight, Obesity, and Depression: A 
Systematic Review and Meta-analysis of 
Longitudinal Studies. Arch Gen Psych. 2010 Mar 
;67(3):220–229. 
doi:10.1001/archgenpsychiatry.2010.2 
19. Chatuvedi A, Botch S, Ricaurte E. Toxicological 
findings in 889 fatally injured obese pilots involved 
in aviation accidents. J Forensic Sci.2012 Mar. 57 
(2): 420-425 
20. UK Civil Aviation Authority Guidance Material 
Version 1.0 17/09/2012 
https://www.caa.co.uk/medical/obesity [accessed 
20 Aug 2020] 
 
